Evidence map›Paper›PMID 33312108›Full record

ArticleEXCLI journal2020

Interferon therapy for preventing COPD exacerbations.

Meenu Mehta, Keshav R Paudel, Shakti D Shukla, Madhur D Shastri, Sachin K Singh, Monica Gulati, Harish Dureja, Gaurav Gupta, Saurabh Satija, Philip M Hansbro and 2 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EXCLI journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 3 countries.

Meenu MehtaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia.
Keshav R PaudelCentre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia.
Shakti D ShuklaPriority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, NSW 2305, Australia.
Madhur D ShastriSchool of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia.
Sachin K SinghSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
Monica GulatiSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
Harish DurejaDepartment of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India.
Gaurav GuptaSchool of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India.
Saurabh SatijaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia.
Philip M HansbroCentre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia.
Dinesh K ChellappanDepartment of Life Sciences, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia.
Kamal DuaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia.
Lovely Professional University · INCentenary Institute · AUUniversity of Technology Sydney · AUGyan Vihar University · INHunter Medical Research Institute · AUInternational Medical University · MYMaharshi Dayanand University · INUniversity of Tasmania · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33312108
PMCPMC7726488
OpenAlexW3115851070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.